Skip to main content
Psychopharmacology Bulletin All Volumes & Issues VOL 44 No. 3 Antipsychotic Induced Symptomatic...
GENERAL PSYCHIATRY

Antipsychotic Induced Symptomatic Hyperprolactinemia: Are Dopamine Agonists Safe?

Psychopharmacology Bulletin 44(3) :66-68 , 2011/09/15

Abstract

Published literature shows that dopamine agonists can reverse antipsychotic-induced hyperprolactinemia without worsening psychotic symptoms in the majority of schizophrenic patients. However, psychiatrists have been reluctant to use drugs with dopaminergic properties for fear of exacerbating psychiatric symptoms. There are reported cases of psychosis worsening published for both cabergoline and bromocriptine. Cabergoline has proven to be more effective and safe when used to treat hyperprolactinemia, but whether cabergoline is also safer than bromocriptine in antipsychotic induced hyperprolactinemia remains unproven.

Access This Article

Choose an access option below to view the full article.

Subscriber Access

If you or your institution has a subscription, log in to access this article.

Log In

Purchase Article

Buy single-article access with a one-time purchase.

$30.00
Add to Cart

How to Cite

Unax Lertxundi, Saioa Domingo-Echaburu, Javier Peral, Montserrat García. Antipsychotic Induced Symptomatic Hyperprolactinemia: Are Dopamine Agonists Safe?. Psychopharmacology Bulletin. 2011/09/15; 44(3):66-68.